相关实验视频
Updated: Sep 16, 2025

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.4K
由UBQLN2招募E3酶可以保护基质免受蛋白质体降解
bioRxiv : the preprint server for biology
|July 9, 2025
概括
尤比基林,特别是UBQLN2,通过形成相分离凝聚物,独特地保护蛋白质免受降解,ALS突变的功能受损,揭示了神经退行性疾病的新范式.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 蛋白质降解 蛋白质降解
背景情况:
- 乌比基林对蛋白质稳定至关重要,但它们在基质稳定中的作用,特别是在像ALS这样的神经退行性疾病中,尚不清楚.
- UBQLN2中的特定突变会导致X相关的ALS,但这些缺陷的机制基础仍然不清楚.
- 乌比基林相分离的功能和对特异性的作用尚未得到很好的定义.
研究的目的:
- 阐明UBQLN2在基质分类和蛋白质稳定中的独特作用.
- 调查UBQLN2基质稳定和ALS突变影响的机制基础.
- 探索乌比奎林相分离在蛋白质稳定和神经退行过程中的作用.
主要方法:
- 使用的三重淘汰 (TKO) 救援细胞系表达单个乌比基林对应物或ALS突变体.
- 通过监测蛋白质降解来研究基质稳定.
- 分析了Ubiquilins的E3酶的招募和相分离特性.
主要成果:
- UBQLN2独特地保护基质免受降解,与E3酶招募相关 (例如,SCFbxo7).
- 招募E3酶促进UBQLN2相分离,导致基质稳定.
- 突变的ALS表现出基质稳定和改变相位分离的缺陷.
结论:
- UBQLN2通过E3酶介导相分离稳定基质,为Ubiquilin功能提供了一个新的模型.
- 在ALS突变体中受损的基质稳定突出显示了神经退行性疾病中一种新的机制.
- 通过Ubiquilin凝结物的蛋白质稳定,以APP为例,是一种可概括的现象.
相关概念视频
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
The Proteasome Structure
987
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
987
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Intralumenal Vesicles and Multivesicular Bodies
3.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.7K

